Published in Am Heart J on February 01, 1982
Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med (1989) 3.44
Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.50
Diagnosis of pulmonary embolism. CMAJ (2003) 1.31
The pulmonary physician and critical care. 5. Management of pulmonary embolism. Thorax (1992) 1.08
Management of pulmonary embolism. Br Med J (Clin Res Ed) (1982) 1.04
Sonothrombolysis. Adv Exp Med Biol (2016) 0.78
Pulmonary embolism--a concept for survival. J Natl Med Assoc (1991) 0.75
Pseudoinfarction in patients with massive pulmonary embolism. West J Med (1986) 0.75
Trends in pulmonary embolism death rates for Canada and the United States, 1962-87. CMAJ (1990) 0.75
Impact of thromboprophylaxis across the US acute care setting. PLoS One (2015) 0.75
Unsuspected pulmonary thromboemboli: a continuing clinical challenge. Tex Heart Inst J (2013) 0.75
A Rare Case of Acute Pulmonary Embolism after Coronary Angiography due to Sand Bag Compression. Int J Angiol (2013) 0.75
Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med (2000) 5.43
Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) (1977) 3.20
Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol (1988) 2.60
Therapeutic defibrination in the treatment of thrombotic disease. Lancet (1968) 2.40
The nephrotic syndrome associated with secondary syphilis. An immune deposit disease. Am J Med (1970) 2.37
Hemostasis in massively transfused trauma patients. Ann Surg (1979) 2.12
A comparative analysis of pulmonary perfusion scans with pulmonary angiograms. Am Heart J (1976) 1.93
Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine (Baltimore) (1981) 1.88
Current concepts: guidelines for the use of thrombolytic agents. N Engl J Med (1979) 1.82
Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol (1978) 1.79
The clinical features of submassive and massive pulmonary emboli. Am J Med (1977) 1.77
Iron stores in blood donors. JAMA (1981) 1.75
Letter: Dilantin, agranulocytosis, and phagocytic marrow histiocytes. Ann Intern Med (1976) 1.63
Disseminated intravascular coagulation and portal hypertension following pancreatic islet autotransplantation. Ann Surg (1980) 1.58
Typhoid fever. Studies of blood coagulation, bacteremia, and endotoxemia. Arch Intern Med (1978) 1.52
Coronary thrombosis in myocardial infarction. Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction. Am J Cardiol (1974) 1.51
Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients. Ann Intern Med (1976) 1.46
Oxidative damage in age-related macular degeneration. Histol Histopathol (2007) 1.44
Acetaminophen and warfarin: undesirable synergy. JAMA (1998) 1.43
Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrow. Pharmacogenomics J (2003) 1.41
The effect of arvin on blood coagulation factors. Br J Haematol (1968) 1.39
Trousseau's syndrome. Devastating coagulopathy in the absence of heparin. Am J Med (1985) 1.38
Binding and endocytosis of cluster glycosides by rabbit hepatocytes. Evidence for a short-circuit pathway that does not lead to degradation. J Biol Chem (1982) 1.32
Disorganization of cultured vascular endothelial cell monolayers by fibrinogen fragment D. Science (1985) 1.19
The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. A clinicopathologic study of 17 autopsied patients. Ann Intern Med (1979) 1.16
Localization of a fibrinogen calcium binding site between gamma-subunit positions 311 and 336 by terbium fluorescence. J Biol Chem (1985) 1.16
Microscopic method for assaying F cell production: illustrative changes during infancy and in aplastic anemia. Blood (1978) 1.15
Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem (1988) 1.12
Carbohydrate structure of human fibrinogen. Use of 300-MHz 1H-NMR to characterize glycosidase-treated glycopeptides. J Biol Chem (1982) 1.07
Disseminated intravascular coagulation. Johns Hopkins Med J (1980) 1.06
Thrombolytic therapy: Current status. N Engl J Med (1975) 1.05
Envenomation coagulopathy in wounds from pit vipers. N Engl J Med (1981) 1.04
The rfaE gene from Escherichia coli encodes a bifunctional protein involved in biosynthesis of the lipopolysaccharide core precursor ADP-L-glycero-D-manno-heptose. J Bacteriol (2000) 1.02
A prospective study of blood donations in healthy elderly persons. Transfusion (1991) 1.02
Disseminated intravascular coagulation during heparin therapy. Ann Intern Med (1974) 1.01
Lymphocyte phenotypes in infants are altered by separation of blood on density gradients. Br J Biomed Sci (1993) 1.01
Cimetidine potentiation of the hypoprothrombinemic effect of warfarin. Ann Intern Med (1979) 1.00
Fibrinogen sialic acid residues are low affinity calcium-binding sites that influence fibrin assembly. J Biol Chem (1989) 1.00
Microwave technology for the rapid thawing of frozen blood components. Am J Clin Pathol (1985) 1.00
Pseudothrombocytopenia: manifestation of a new type of platelet agglutinin. Blood (1973) 1.00
Iron stores and iron absorption: effects of repeated blood donations. Am J Clin Nutr (1995) 0.99
Multivariate time series projections of parameterized age-specific fertility rates. J Am Stat Assoc (1989) 0.98
Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection. J Clin Invest (1996) 0.98
Heparin-associated thrombocytopenia: a comparison of three heparin preparations. N Engl J Med (1980) 0.98
Variations in the frequency of fetal hemoglobin-bearing erythrocytes (F-cells) in well adults, pregnant women, and adult leukemics. Johns Hopkins Med J (1975) 0.97
The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man. J Lab Clin Med (1978) 0.96
Metastatic intravagal paraganglioma. Case report and review of the literature. Am J Med (1985) 0.95
Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery. Ann Thorac Surg (1984) 0.95
The synergistic activity of intra-amniotic prostaglandin F2 alpha and urea in the midtrimester elective abortion. Am J Obstet Gynecol (1974) 0.95
Thrombolytic therapy for inferior vena cava thrombosis in paroxysmal nocturnal hemoglobinuria. Ann Intern Med (1985) 0.95
Lymphocytaplasmapheresis in Devic's syndrome. Transfusion (1985) 0.92
Editorial: Thrombocytopenia occurring during heparin therapy. N Engl J Med (1976) 0.92
Heparin-induced coagulopathy. J Lab Clin Med (1977) 0.91
Effects of arvin on blood platelets. In vitro and in vivo studies. J Lab Clin Med (1972) 0.90
Pulmonary embolism: progress and problems. Am J Med (1982) 0.89
In vivo behavior of radioiodinated rabbit antithrombin III. Demonstration of a noncirculating vascular compartment. J Clin Invest (1984) 0.89
Polymyalgia rheumatica. Johns Hopkins Med J (1967) 0.88
Chronic myelocytic leukemia with two Philadelphia chromosomes and prominent peripheral lymphadenopathy. Blood (1967) 0.88
Megakaryocyte-targeted synthesis of the integrin beta(3)-subunit results in the phenotypic correction of Glanzmann thrombasthenia. Blood (2000) 0.88
A comparison of hyperacute canine renal allograft and sheep-to-dog xenograft rejection. Transplantation (1972) 0.88
Natural history of autologous blood clot embolization in swine. Invest Radiol (1976) 0.88
In vivo behavior of human radioiodinated antithrombin III: distribution among three physiologic pools. Blood (1985) 0.87
Antithrombotic practice in orthopedic surgery. Results of a survey. Clin Orthop Relat Res (1975) 0.87
Blood fibrinolytic activity during arvin therapy. Br J Haematol (1969) 0.87
Direct spectrophotometry of serum hemoglobin: an Allen correction compared with a three-wavelength polychromatic analysis. Clin Chem (1984) 0.87
Iron supplementation for menstruating female blood donors. Transfusion (1985) 0.87
Streptokinase salvage of renal function after renal vein thrombosis. Ann Intern Med (1984) 0.86
Binding and endocytosis of glycoproteins and neoglycoproteins by isolated rabbit hepatocytes. Biochem J (1983) 0.86
Cytogenetic and morphologie abnormalities in human bone marrow cells during cytosine arabinoside therapy. Blood (1966) 0.86
Diagnosis and treatment of anticoagulant-related adrenal hemorrhage. Am J Hematol (1981) 0.85
The effects of red blood cell infusion on 10-km race time. JAMA (1987) 0.85
Disseminated intravascular coagulation in prostatic carcinoma reversed by ketoconazole. JAMA (1987) 0.85
Post-transfusion purpura: a report of five patients and a review of the pathogenesis and management. Am J Hematol (1986) 0.85
Autotransfusion of shed mediastinal blood after cardiac surgery: a prospective study. J Thorac Cardiovasc Surg (1978) 0.85
Familial multiple coagulation factor deficiencies. II. Combined factor VIII, IX, and XI deficiency and combined factor IX and XI deficiency: two previously uncharacterized familial multiple factor deficiency syndromes. Semin Thromb Hemost (1981) 0.85
Abnormalities of the spleen and liver in patients with hemophilia. Am J Hematol (1983) 0.84
Stimulation of fibrinogen synthesis: a possible functional role of fibrinogen degradation products. Blood (1980) 0.84
Management of priapism by therapeutic defibrination. N Engl J Med (1969) 0.84
The normal and morbid biology of fibrinogen. Am J Med (1989) 0.84
The use of ancrod to prevent thrombosis on prosthetic heart valves. An experimental study. Thorax (1970) 0.84
Plasma proteins and lymphocyte phenotypes in long-term plasma donors. Transfusion (1994) 0.84
Extension of platelet concentrate storage to 7 days in second-generation bags. Transfusion (1987) 0.83
Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits. Am J Physiol (1989) 0.83
Coronary thrombolysis with recombinant tissue-type plasminogen activator. A hematologic and pharmacologic study. Ann Intern Med (1985) 0.83
The urokinase-streptokinase pulmonary embolism trial (phase II) results. Circulation (1974) 0.83
Obstetric complications in a patient with Bernard-Soulier syndrome. Am J Obstet Gynecol (1991) 0.83
Normal viability of platelet concentrates obtained from CPDA-1 blood after storage in CL-3000 blood containers. Vox Sang (1982) 0.83
Breath ethane: a specific indicator of free-radical-mediated lipid peroxidation following reperfusion of the ischemic liver. Free Radic Biol Med (1992) 0.83
The effect of homologous thrombin and fibrinogen degradation products on fibrinogen synthesis in rabbits. J Lab Clin Med (1979) 0.83
The effect of Arvin on experimental immune arthritis in rabbits. Br J Exp Pathol (1970) 0.82
Fibrinogen synthesis in rabbits: effects of altered levels of circulating fibrinogen. Am J Physiol (1977) 0.82
Prevalence of HTLV-III antibody among New Mexico residents with hemophilia. West J Med (1986) 0.82
A unique circulating inhibitor with specificity for coagulation factor X. Am J Med (1992) 0.82
Control of heparin therapy in open-heart surgery. J Thorac Cardiovasc Surg (1974) 0.82
Heparin pharmacokinetics: increased requirements in pulmonary embolism. Br J Haematol (1978) 0.82
Yersinia pestis infection in Vietnam. I. Clinical and hematologic aspects. J Infect Dis (1974) 0.82